WhaleCreep
Home › Funds › 22NW, LP › Q1 2025

22NW, LP 13F holdings, Q1 2025

Holdings as of March 31, 2025 · filings on SEC EDGAR · latest filing →

22NW, LP disclosed 20 US equity positions worth $149.1m in its Q1 2025 13F filing. The largest position was LFCR at 20.0% of the reported book, followed by FSTR and ANEB. Against the Q4 2024 filing, it opened 7 new positions, added to 3 and reduced 1 among the top 20 holdings.

← Q4 2024 · Q2 2025 →

What did 22NW, LP own in Q1 2025? Top 20 positions

#StockSectorWeightValueSharesΔ sharesvs Q4 2024
1 LFCR LIFECORE BIOMEDICAL INC 20.0%$29.8m1,755,161 0% held
2 FSTR FOSTER L B CO Industrials 17.3%$25.8m1,313,121 0% held
3 ANEB ANEBULO PHARMACEUTICALS INC 13.5%$20.1m15,467,300 0% held
4 STRL STERLING INFRASTRUCTURE INC Industrials 7.6%$11.3m99,783 0% held
5 CULP CULP INC 6.2%$9.3m1,859,061 14% added
6 SRI STONERIDGE INC Consumer Cyclical 5.0%$7.5m1,627,653 375% added
7 MLYS MINERALYS THERAPEUTICS INC Healthcare 4.9%$7.3m461,344 – new
8 PHENIXFIN CORP 4.2%$6.2m117,885 0% held
9 BBSI BARRETT BUSINESS SVCS INC Industrials 3.7%$5.5m132,452 -50% reduced
10 RGNX REGENXBIO INC Healthcare 3.2%$4.8m668,679 – new
11 FB1 FARMER BROS CO 2.9%$4.3m1,955,526 0% held
12 DHX DHI GROUP INC Technology 2.4%$3.6m2,603,643 0% held
13 UFI UNIFI INC Consumer Cyclical 2.4%$3.5m731,535 213% added
14 ELDN ELEDON PHARMACEUTICALS INC 1.4%$2.2m636,364 – new
15 CMPS COMPASS PATHWAYS PLC Healthcare 1.2%$1.8m646,559 – new
16 KROS KEROS THERAPEUTICS INC Healthcare 1.2%$1.8m179,000 – new
17 NKTR NEKTAR THERAPEUTICS Healthcare 1.0%$1.5m2,191,750 0% held
18 SSKN STRATA SKIN SCIENCES INC 1.0%$1.4m536,995 0% held
19 PMDUSD PSYCHEMEDICS CORPORATION CMN 0.4%$643.2k276,034 – new
20 TISI TEAM INC 0.4%$589.4k34,835 – new

Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.